2-chloroadenine has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Huang, Y; Li, Z; Luo, HB; Wu, XN; Wu, Y; Zheng, D; Zhou, Q | 1 |
| Akula, KK; Dhir, A; Kulkarni, SK | 1 |
2 other study(ies) available for 2-chloroadenine and Disease Models, Animal
| Article | Year |
|---|---|
Rational Design of 2-Chloroadenine Derivatives as Highly Selective Phosphodiesterase 8A Inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Administration, Oral; Animals; Behavior, Animal; Binding Sites; Crystallography, X-Ray; Dementia, Vascular; Disease Models, Animal; Drug Design; Half-Life; Humans; Inhibitory Concentration 50; Isoenzymes; Mice; Molecular Dynamics Simulation; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2020 |
Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism.
Topics: Adenine; Adenosine; Analysis of Variance; Animals; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Lactones; Male; Mice; Pentylenetetrazole; Seizures; Sulfones | 2008 |